Страна: Нова Зеландія
мова: англійська
Джерело: Medsafe (Medicines Safety Authority)
Laropiprant 20mg; ; Nicotinic acid 1000mg
Merck Sharp & Dohme (New Zealand) Limited
Laropiprant 20 mg
Tablet
Active: Laropiprant 20mg Nicotinic acid 1000mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hyprolose Hypromellose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Sodium stearyl fumarate
Blister pack, Al/Al - 7 tablets, 7 tablets
Prescription
Prescription
F.I.S. Fabbrica Italiana Sintetici SpA
Package - Contents - Shelf Life: Blister pack, Al/Al - 7 tablets - 7 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 14 tablets - 14 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 28 tablets - 28 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 56 tablets - 56 tablets - 24 months from date of manufacture stored at or below 30°C
2007-08-29